Get our free email newsletter

Google Developing Pill that Detects Illness

Google Developing Pill that Detects Illness | In Compliance Magazine

Google is experimenting with placing nanoparticles inside a pill to search for malignant cells in a patient’s bloodstream. A patient swallows the pill and a sensor on a wearable device reports back findings to a doctor providing better insight into what is happening inside their patient’s body.

The nanoparticles are coated with antibodies that would attach to specific proteins or cells. The particles would remain in the blood supply and continuously report data back to the sensor. The sensor would also track the particle’s movement through the body using magnetic fields. The goal of the project is to give doctors more information about a patient’s health compared to results of a blood sample.

- Partner Content -

Mastering High Voltage: The Importance of Accurate Test Equipment

This whitepaper underscores that precise calibration of high-voltage test gear — especially when measuring 1 kV–150 kV systems — is essential for safety, reliability, and regulatory compliance. It details measurement techniques (voltage dividers, step-down transformers, etc.), the impact of environmental and connection factors on accuracy, and why traceable calibration (e.g. to NIST / A2LA) is a must to ensure consistent, reliable results.

Read more about the development of a pill that would detect cancer and other illnesses.

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, and check out trending engineering news.

Get our email updates

What's New

- From Our Sponsors -

Don't Let Regulations

Derail Your Designs

Get free access to:

Close the CTA
  • Expert analysis of emerging standards
  • EMC and product safety technical guidance
  • Real-world compliance solutions

Trusted by 30,000+ engineering professionals

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, and trending engineering news.

Close the CTA